Merck (MRK) Accumulated Expenses (2009 - 2011)

Merck has disclosed Accumulated Expenses across 3 years of filings, most recently posting $8.6 billion for Q1 2011.

• In Q1 2011, Accumulated Expenses rose 1.37% year-over-year to $8.6 billion; the TTM figure through Mar 2011 stood at $8.6 billion (up 1.37% YoY), while the FY2010 annual figure was $8.5 billion, down 9.95% from the prior year.
• Accumulated Expenses was little changed at $8.6 billion in Q1 2011, from $8.5 billion in the prior quarter.
• Over the last five years, Accumulated Expenses for MRK reached as high as $9.5 billion in Q4 2009 and fell as low as $828.0 million in Q2 2009.
• The 3-year median for Accumulated Expenses is $8.3 billion (2010), against an average of $6.5 billion.
• The widest YoY moves for Accumulated Expenses: up 743.8% in 2010, down 9.95% in 2010.
• A 3-year view of Accumulated Expenses shows it stood at $9.5 billion in 2009, then declined by 9.95% to $8.5 billion in 2010, then advanced by 0.48% to $8.6 billion in 2011.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $8.6 billion, $8.5 billion, and $8.2 billion for Q1 2011, Q4 2010, and Q3 2010 respectively.